Sunesis Pharmaceuticals
| Region | Nordamerika |
| ISIN | US8673288747 |
| Sektor | Biotechnologie |
| Website | https://www.sunesis.com/ |
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.
| Titel | Autor | Datum |
|---|---|---|
|
Risikoarmes "Peak Play" mit Multibagger-Potenzial
|
sharedeals | vor ungefähr 5 Jahren |
| Titel | Datum |
|---|---|
| MISC Should Ease Into 2026 Smoothly | vor 9 Tagen |
| MISC Group expands dual-fuel fleet through AET's new Suezmax contracts | vor 10 Tagen |
| MISC Orders LNG Dual-Fuel Suezmax Pair in Fleet Renewal Drive | vor 10 Tagen |
| MISC Posted 60% Jump In Q3 Profit To RM541 Million Despite Lower Revenue | vor 10 Tagen |
| MISC 3Q net profit rises 60%, declares dividend of eight sen per share | vor 10 Tagen |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Suedzucker (1 Artikel) | |
| Stockholm IT Ventures AB (1 Artikel) | |
| Tahoe Resources (1 Artikel) | |
| Telit Communications (3 Artikel) | |
| Alle anzeigen | |